Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Levesque

Showing results (161-170 of 281) with videos related to

Pageof 29
Sort By:
Oncogene|April 3, 2020
Temporal activation of WNT/β-catenin signaling is sufficient to inhibit SOX10 expression and block melanoma growthRexhep Uka, Christian Britschgi, Anja Krättli, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 16, 2018
VLA-4 mediated adhesion of melanoma cells on the blood-brain barrier is the critical cue for melanoma cell intercalation and barrier disruptionAna B García-Martín, Pascale Zwicky, Thomas Gruber, et al.
RNA Biology|August 22, 2022
The A to I editing landscape in melanoma and its relation to clinical outcomeAusteja Amweg, Marina Tusup, Phil Cheng, et al.
Science Advances|January 13, 2023
Escape from NK cell tumor surveillance by NGFR-induced lipid remodeling in melanomaJulia Lehmann, Nicole Caduff, Ewelina Krzywińska, et al.
Dermatopathology (Basel, Switzerland)|April 6, 2016
Coexpression of SOX10/CD271 (p75(NTR)) and β-Galactosidase in Large to Giant Congenital Melanocytic Nevi of Pediatric PatientsMarjam J Barysch, Mitchell P Levesque, Phil Cheng, et al.
Leukemia & Lymphoma|May 1, 1996
CD44 and hyaluronan binding by human myeloid cellsF Smadja-Joffe, S Legras, N Girard, et al.
The Review of Scientific Instruments|July 5, 2013
In situ "artificial plasma" calibration of tokamak magnetic sensorsD Shiraki, J P Levesque, J Bialek, et al.
Pigment Cell & Melanoma Research|November 6, 2025
Combination of the Novel RAF Dimer Inhibitor Brimarafenib With the MEK Inhibitor Mirdametinib Is Effective Against NRAS Mutant MelanomaFlavia L Tellenbach, Luzia Seiler, Mark Johnson, et al.
Leukemia|September 28, 2013
The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than PlerixaforD Karpova, K Dauber, G Spohn, et al.
JID Innovations : Skin Science From Molecules to Population Health|January 27, 2025
DNA Methyltransferase Inhibition Upregulates the Costimulatory Molecule ICAM-1 and the Immunogenic Phenotype of Melanoma CellsAlessandra S P Cereghetti, Patrick Turko, Phil Cheng, et al.
Pageof 29

Showing results (161-170 of 281) with videos related to

Sort By:
Pageof 29
Oncogene|April 3, 2020
Temporal activation of WNT/β-catenin signaling is sufficient to inhibit SOX10 expression and block melanoma growthRexhep Uka, Christian Britschgi, Anja Krättli, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 16, 2018
VLA-4 mediated adhesion of melanoma cells on the blood-brain barrier is the critical cue for melanoma cell intercalation and barrier disruptionAna B García-Martín, Pascale Zwicky, Thomas Gruber, et al.
RNA Biology|August 22, 2022
The A to I editing landscape in melanoma and its relation to clinical outcomeAusteja Amweg, Marina Tusup, Phil Cheng, et al.
Science Advances|January 13, 2023
Escape from NK cell tumor surveillance by NGFR-induced lipid remodeling in melanomaJulia Lehmann, Nicole Caduff, Ewelina Krzywińska, et al.
Dermatopathology (Basel, Switzerland)|April 6, 2016
Coexpression of SOX10/CD271 (p75(NTR)) and β-Galactosidase in Large to Giant Congenital Melanocytic Nevi of Pediatric PatientsMarjam J Barysch, Mitchell P Levesque, Phil Cheng, et al.
Leukemia & Lymphoma|May 1, 1996
CD44 and hyaluronan binding by human myeloid cellsF Smadja-Joffe, S Legras, N Girard, et al.
The Review of Scientific Instruments|July 5, 2013
In situ "artificial plasma" calibration of tokamak magnetic sensorsD Shiraki, J P Levesque, J Bialek, et al.
Pigment Cell & Melanoma Research|November 6, 2025
Combination of the Novel RAF Dimer Inhibitor Brimarafenib With the MEK Inhibitor Mirdametinib Is Effective Against NRAS Mutant MelanomaFlavia L Tellenbach, Luzia Seiler, Mark Johnson, et al.
Leukemia|September 28, 2013
The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than PlerixaforD Karpova, K Dauber, G Spohn, et al.
JID Innovations : Skin Science From Molecules to Population Health|January 27, 2025
DNA Methyltransferase Inhibition Upregulates the Costimulatory Molecule ICAM-1 and the Immunogenic Phenotype of Melanoma CellsAlessandra S P Cereghetti, Patrick Turko, Phil Cheng, et al.
Pageof 29